Ralexar Therapeutics Patents – Insights & Stats (Updated 2023)

Ralexar Therapeutics has a total of 51 patents globally, out of which 25 have been granted. Of these 51 patents, more than 33% patents are active. The USA is where Ralexar Therapeutics has filed the maximum number of patents. Parallelly, the United States seems to be the main focused R&D center of Ralexar Therapeutics and is also the origin country of the firm. Ralexar Therapeutics was founded in the year 2013 by Raju Mohan. The company develops topical and systemic therapies designed to treat various dermatological conditions. Do read about some of the most popular patents of Ralexar Therapeutics which have been covered by us in this article and also you can find Ralexar Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Ralexar Therapeutics patent portfolio.

How many patents does Ralexar Therapeutics have?

Ralexar Therapeutics has a total of 51 patents globally. These patents belong to 7 unique patent families. Out of 51 patents, 17 patents are active.

How Many Patents did Ralexar Therapeutics File Every Year?

Ralexar Therapeutics Patent Filing Trend Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.  
Year of Patents Filing or Grant Ralexar Therapeutics Applications Filed Ralexar Therapeutics Patents Granted
2022
2021 1
2020 1 3
2019 1 7
2018 6 8
2017 2 4
2016
2015 2 2
2014 13
2013 26
2012
2011
 

How many Ralexar Therapeutics patents are Alive/Dead?

Worldwide Patents Ralexar Therapeutics Patent Portfolio

How Many Patents did Ralexar Therapeutics File in Different Countries?

Ralexar Therapeutics Worldwide Patent Filing Countries in which Ralexar Therapeutics Filed Patents
Country Patents
United States Of America 7
Singapore 3
Korea (South) 3
Japan 3
Europe 3
Canada 2
China 2
New Zealand 2
Hong Kong (S.A.R.) 2
Australia 2
Brazil 2
Israel 2
Spain 1
Serbia 1
Poland 1
Hungary 1
Slovakia 1
Albania 1
Germany 1
Cyprus 1
Portugal 1
Denmark 1
Austria 1
Lithuania 1
Slovenia 1
Malta 1
Turkey 1
Estonia 1
Croatia 1
Norway 1

 

Where are Research Centres of Ralexar Therapeutics Patents Located?

R&D Centres of Ralexar Therapeutics

Most Cited Ralexar Therapeutics Patents

US8987318B2 is the most popular patent in the Ralexar Therapeutics portfolio. It has received 6 citations so far.

What are Ralexar Therapeutics key innovation segments?

What Technologies are Covered by Ralexar Therapeutics?

The chart below distributes patents filed by Ralexar Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Ralexar Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Ralexar Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Ralexar Therapeutics?

Related Articles

Alphapharm Patents – Insights & Stats (Updated 2024)

Alphapharm has a total of 108 patents globally, out of which 43 have been granted. Of these 108 patents, more than 18% patents are active. Australia is where Alphapharm has filed the maximum number of patents, followed by Europe (EPO) and United States of America. Parallelly, Australia seems to be

Read More »

Complexa Patents – Insights & Stats (Updated 2024)

Complexa has a total of 77 patents globally, out of which 16 have been granted. Of these 77 patents, more than 22% patents are active. The United States of America is where Complexa has filed the maximum number of patents, followed by Japan. Parallelly, United States of America seems to

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.